Contact

All Stories

  1. Challenges of heart failure pharmacotherapy in obesity

    Article • European Journal of Heart Failure, January 2026, Oxford University Press (OUP)

    Prof. Dr. Martin Schulz

  2. Increasing use of non-statin and combination lipid-lowering therapies 2012–2025: a nationwide study

    Article • European Journal of Preventive Cardiology, November 2025, Oxford University Press (OUP)

    Prof. Dr. Martin Schulz

  3. Temporal trends in the prescription of low-dose antithrombotic and anti-inflammatory therapies in Germany (2022–2024)

    Article • Clinical Research in Cardiology, October 2025, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  4. Inhaler use and their carbon footprint in Germany: a 10-year analysis (2013–2022)

    Article • BMJ Open Respiratory Research, October 2025, BMJ

    Prof. Dr. Martin Schulz

  5. The role of pharmacists in the management of patients with atrial fibrillation: A systematic review and meta-analysis

    Article • Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, August 2025, SAGE Publications

    Prof. Dr. Martin Schulz

  6. 100 Million Pens a Year in Germany: And Then in the Trash?

    Article • Journal of Diabetes Science and Technology, August 2025, SAGE Publications

    Prof. Dr. Martin Schulz

  7. Management of patients with heart failure at high risk of hyperkalaemia: The CARE ‐ HK in HF registry

    Article • European Journal of Heart Failure, August 2025, Oxford University Press (OUP)

    Prof. Dr. Martin Schulz

  8. Reply to ‘Expanding the horizon of medication adherence strategies in acutely decompensated heart failure’

    Article • European Journal of Heart Failure, July 2025, Oxford University Press (OUP)

    Prof. Dr. Martin Schulz

  9. Medication adherence in patients with acutely decompensated heart failure: A cross‐sectional study in the emergency department ( ADHF ‐ ED )

    Article • European Journal of Heart Failure, July 2025, Oxford University Press (OUP)

    Prof. Dr. Martin Schulz

  10. Fostering collaboration: a controlled pilot study of interprofessional education for medical and pharmacy students

    Article • BMC Medical Education, June 2025, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  11. Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalemia or High Risk of Hyperkalemia: Rationale and Design of the CARE-HK in HF Registry

    Article • Journal of Cardiac Failure, June 2025, Elsevier

    Prof. Dr. Martin Schulz

  12. Treatment pathways of lipid-lowering therapies in Germany 2016–2022

    Article • Clinical Research in Cardiology, May 2025, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  13. Time for a new perspective on polypharmacy in heart failure

    Article • European Journal of Heart Failure, March 2025, Oxford University Press (OUP)

    Prof. Dr. Martin Schulz

  14. The utilization of discharge prescriptions in Germany

    Article • Deutsches Ärzteblatt international, August 2024, Deutscher Arzte-Verlag GmbH

    Prof. Dr. Martin Schulz

  15. Use of fixed-dose combinations for cardiovascular indications from 2018 to 2023: a nationwide population-based study

    Article • Journal of Hypertension, June 2024, Wolters Kluwer Health

    Prof. Dr. Martin Schulz

  16. DECLINING RATES OF FIXED-DOSE COMBINATION PILLS FOR HYPERTENSION IN GERMANY FROM 2016 TO 2023

    Article • Journal of Hypertension, May 2024, Wolters Kluwer Health

    Prof. Dr. Martin Schulz

  17. Inconclusiveness of psychometric testing of medication adherence questionnaires

    Article • European Journal of Clinical Pharmacology, April 2024, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  18. Development and validation of the 15-STARS - A novel self-report pharmacy-based questionnaire to screen for medication non-adherence

    Article • Research in Social and Administrative Pharmacy, March 2024, Elsevier

    Prof. Dr. Martin Schulz

  19. Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers

    Article • Clinical Pharmacokinetics, February 2024, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  20. Knowledge and attitudes of German and Swiss community pharmacists towards biologicals and biosimilars – a prospective survey before and after the COVID-19 pandemic

    Article • BMC Health Services Research, December 2023, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  21. Impact of the COVID-19 pandemic on implementation of novel guideline-directed medical therapies for heart failure in Germany: a nationwide retrospective analysis

    Article • The Lancet Regional Health - Europe, December 2023, Elsevier

    Prof. Dr. Martin Schulz

  22. Hidden sodium in effervescent-tablet dietary supplements and over-the-counter drugs: a comparative cross-sectional study

    Article • BMJ Open, November 2023, BMJ

    Prof. Dr. Martin Schulz

  23. Patients’ Use of a Standardized Medication List - A Mixed Methods Study

    Article • Patient Preference and Adherence, October 2023, Taylor & Francis

    Prof. Dr. Martin Schulz

  24. A complex intervention to prevent medication-related hospital admissions—results of the stepped-wedge cluster randomized trial KiDSafe in pediatrics

    Article • Deutsches Ärzteblatt international, June 2023, Deutscher Arzte-Verlag GmbH

    Prof. Dr. Martin Schulz

  25. Kardiovaskuläre Pharmakotherapie im Alter

    Article • Herz, June 2023, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  26. Not obtaining a medication the first time it is prescribed: primary non-adherence to cardiovascular pharmacotherapy

    Article • Clinical Research in Cardiology, May 2023, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  27. Mortality and hospitalizations among patients enrolled in an interprofessional medication management program

    Article • Deutsches Ärzteblatt international, April 2023, Deutscher Arzte-Verlag GmbH

    Prof. Dr. Martin Schulz

  28. Implementing standardized medication plans in ambulatory care – Are they correct and do patients follow their plan?

    Article • March 2023, Research Square

    Prof. Dr. Martin Schulz

  29. Association of hydrochlorothiazide treatment compared with alternative diuretics with overall and skin cancer risk: a propensity-matched cohort study

    Article • Journal of Hypertension, March 2023, Wolters Kluwer Health

    Prof. Dr. Martin Schulz

  30. Self-care and self-medication as central components of healthcare in Germany – on the way to evidence-based pharmacy

    Article • Exploratory Research in Clinical and Social Pharmacy, March 2023, Elsevier

    Prof. Dr. Martin Schulz

  31. Assessment of the Prescriptions of Systemic Antibiotics in Primary Dental Care in Germany from 2017 to 2021: A Longitudinal Drug Utilization Study

    Article • Antibiotics, November 2022, MDPI AG

    Prof. Dr. Martin Schulz

  32. Clinical pharmacy services are reimbursed in Germany: challenges of real world implementation remain

    Article • International Journal of Clinical Pharmacy, November 2022, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  33. Attitudes of non-participating general practitioners and community pharmacists towards interprofessional medication management in primary care: an interview study

    Article • International Journal of Clinical Pharmacy, October 2022, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  34. A prediction model for nonpersistence or nonadherence to direct oral anticoagulants in hospitalized patients with atrial fibrillation

    Article • Journal of Managed Care & Specialty Pharmacy, October 2022, Academy of Managed Care Pharmacy

    Prof. Dr. Martin Schulz

  35. Task sharing in an interprofessional medication management program – a survey of general practitioners and community pharmacists

    Article • BMC Health Services Research, August 2022, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  36. Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials

    Article • ESC Heart Failure, August 2022, Wiley

    Prof. Dr. Martin Schulz

  37. Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012–2021

    Article • Frontiers in Cardiovascular Medicine, June 2022, Frontiers

    Prof. Dr. Martin Schulz

  38. Telemonitoring of heart failure patients is reimbursed in Germany: challenges of real-world implementation remain

    Article • European Heart Journal - Digital Health, April 2022, Oxford University Press (OUP)

    Prof. Dr. Martin Schulz

  39. Oral drugs against COVID-19

    Article • Deutsches Ärzteblatt international, April 2022, Deutscher Arzte-Verlag GmbH

    Prof. Dr. Martin Schulz

  40. Use of fixed-dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia

    Article • Clinical Research in Cardiology, February 2022, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  41. The AMULET ménage à trois: nurse, telemedicine support, and remote cardiologist

    Article • European Journal of Heart Failure, January 2022, Wiley

    Prof. Dr. Martin Schulz

  42. Patients’ perception on generating medication plans in an interprofessional medication management program: a mixed-methods study

    Article • Journal of Interprofessional Care, January 2022, Taylor & Francis

    Prof. Dr. Martin Schulz

  43. Community pharmacists' preparedness for substituting biologics and dispensing biosimilars – Lessons learned from a multinational survey

    Article • Exploratory Research in Clinical and Social Pharmacy, December 2021, Elsevier

    Prof. Dr. Martin Schulz

  44. Interdisciplinary Physician-Pharmacist Medication Review for Outpatients With Heart Failure: A Subanalysis of the PHARM-CHF Randomized Controlled Trial

    Article • Frontiers in Pharmacology, September 2021, Frontiers

    Prof. Dr. Martin Schulz

  45. Utilization of drugs with reports on potential efficacy or harm on COVID ‐19 before, during, and after the first pandemic wave

    Article • Pharmacoepidemiology and Drug Safety, July 2021, Wiley

    Prof. Dr. Martin Schulz

  46. The evidence for pharmacist care in outpatients with heart failure: a systematic review and meta‐analysis

    Article • ESC Heart Failure, July 2021, Wiley

    Prof. Dr. Martin Schulz

  47. Quality Appraisal of Ambulatory Oral Cephalosporin and Fluoroquinolone Use in the 16 German Federal States from 2014–2019

    Article • Antibiotics, July 2021, MDPI AG

    Prof. Dr. Martin Schulz

  48. Explosive drug information in the time of COVID-19

    Article • Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, June 2021, SAGE Publications

    Prof. Dr. Martin Schulz

  49. Wie wirken Generikaquoten? Eine Analyse am Beispiel der HIV-Infektion

    Article • Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, April 2021, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  50. Pharmacists’ perception of educational material to improve patient safety

    Article • Medicine, March 2021, Wolters Kluwer Health

    Prof. Dr. Martin Schulz

  51. Primary healthcare policy and vision for community pharmacy and pharmacists in Germany

    Article • Pharmacy Practice, January 2021, JCFCorp SG PTE LTD

    Prof. Dr. Martin Schulz

  52. Pharmacy practice research – A call to action

    Article • Research in Social and Administrative Pharmacy, November 2020, Elsevier

    Prof. Dr. Martin Schulz

  53. Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany

    Article • Pharmaceuticals, October 2020, MDPI AG

    Prof. Dr. Martin Schulz

  54. Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany

    Article • Journal of Human Hypertension, October 2020, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  55. “Dear Doctor” Warning Letter (Rote-Hand-Brief) on Hydrochlorothiazide and Its Impact on Antihypertensive Prescription

    Article • Deutsches Ärzteblatt international, October 2020, Deutscher Arzte-Verlag GmbH

    Prof. Dr. Martin Schulz

  56. Development and implementation of blood pressure screening and referral guidelines for German community pharmacists

    Article • Journal of Clinical Hypertension, August 2020, Wiley

    Prof. Dr. Martin Schulz

  57. Impact of a global leader on pharmaceutical practice and policy around the world

    Article • Journal of Pharmaceutical Policy and Practice, August 2020, Taylor & Francis

    Filipa Costa, Dr martin c henman, Prof. Dr. Martin Schulz

  58. The impact of pharmacist/physician care on quality of life in elderly heart failure patients: results of the PHARM‐CHF randomized controlled trial

    Article • ESC Heart Failure, July 2020, Wiley

    Prof. Dr. Martin Schulz

  59. Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics

    Article • Critical Care, May 2020, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  60. Post-mortem analysis of prescription opioids—A follow-up examination by LC–MS/MS with focus on fentanyl

    Article • Forensic Science International, December 2019, Elsevier

    Prof. Dr. Martin Schulz

  61. The frequency of photosensitizing drug dispensings in Austria and Germany: a correlation with their photosensitizing potential based on published literature

    Article • Journal of the European Academy of Dermatology and Venereology, November 2019, Wiley

    Prof. Dr. Martin Schulz, Adrian Tanew

  62. Trends in dispensing oral emergency contraceptives and safety issues: a survey of German community pharmacists

    Article • International Journal of Clinical Pharmacy, September 2019, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  63. Letter on ‘Pharmacy‐based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM‐CHF randomized controlled trial’: reply

    Article • European Journal of Heart Failure, September 2019, Wiley

    Prof. Dr. Martin Schulz

  64. Pharmacy‐based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM‐CHF randomized controlled trial

    Article • European Journal of Heart Failure, June 2019, Wiley

    Prof. Dr. Martin Schulz

  65. Das Projekt PRIMA – Elektronische Erstellung und Aktualisierung von Medikationsplänen als gemeinsame Aufgabe von Ärzten und Apothekern

    Article • DMW - Deutsche Medizinische Wochenschrift, March 2019, Thieme Publishing Group

    Prof. Dr. Martin Schulz

  66. Comparison of Different Strategies to Measure Medication Adherence via Claims Data in Patients With Chronic Heart Failure

    Article • Clinical Pharmacology & Therapeutics, March 2019, Wiley

    Prof. Dr. Martin Schulz

  67. Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk

    Article • Patient Preference and Adherence, December 2018, Dove Medical Press

    Michael Böhm, Prof. Dr. Martin Schulz, Dr Felix Mahfoud

  68. Drug shortages may compromise patient safety: Results of a survey of the reference pharmacies of the Drug Commission of German Pharmacists

    Article • Health Policy, December 2018, Elsevier

    Prof. Dr. Martin Schulz

  69. Comparing outpatient oral antibiotic use in Germany and the Netherlands from 2012 to 2016

    Article • Pharmacoepidemiology and Drug Safety, September 2018, Wiley

    Prof. Dr. Martin Schulz

  70. Elektronisch unterstützte Kooperation ambulant tätiger Ärzte und Apotheker zur Verbesserung der Arzneimitteltherapiesicherheit

    Article • Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, July 2018, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  71. Der bundeseinheitliche Medikationsplan in der Praxis

    Article • Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, July 2018, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  72. Potentielle Erfolgsindikatoren für die Durchführung von Projekten zur Arzt-Apotheker-Zusammenarbeit – eine systematische Übersicht

    Article • Das Gesundheitswesen, June 2018, Thieme Publishing Group

    Prof. Dr. Martin Schulz

  73. PHARMacy-based interdisciplinary program for patients with Chronic Heart Failure (PHARM-CHF): rationale and design of a randomized controlled trial, and results of the pilot study

    Article • European Journal of Heart Failure, May 2018, Wiley

    Prof. Dr. Martin Schulz

  74. In search of a standard when analyzing medication adherence in patients with heart failure using claims data: a systematic review

    Article • Heart Failure Reviews, October 2017, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  75. Medication knowledge of patients hospitalized for heart failure at admission and after discharge

    Article • Patient Preference and Adherence, November 2016, Dove Medical Press

    Michael Böhm, Prof. Dr. Martin Schulz

  76. Medication adherence and persistence according to different antihypertensive drug classes: A retrospective cohort study of 255,500 patients

    Article • International Journal of Cardiology, October 2016, Elsevier

    Prof. Dr. Martin Schulz

  77. Antwort zum Leserbrief

    Article • Laryngo-Rhino-Otologie, October 2016, Thieme Publishing Group

    Prof. Dr. Martin Schulz

  78. Evaluation of pharmaceutical concerns in Germany: frequency and potential reasons

    Article • Pharmacy Practice, September 2016, JCFCorp SG PTE LTD

    Prof. Dr. Martin Schulz

  79. Non-prescription dispensing of emergency oral contraceptives: Recommendations from the German Federal Chamber of Pharmacists [Bundesapothekerkammer].

    Article • Pharmacy Practice, September 2016, JCFCorp SG PTE LTD

    Prof. Dr. Martin Schulz

  80. Evaluation of pharmaceutical concerns in Germany: frequency and potential reasons. [online supplementary material]

    Article • Pharmacy Practice, September 2016, JCFCorp SG PTE LTD

    Prof. Dr. Martin Schulz

  81. Non-prescription dispensing of emergency oral contraceptives: Recommendations from the German Federal Chamber of Pharmacists [Bundesapothekerkammer]. Online appendix

    Article • Pharmacy Practice, September 2016, JCFCorp SG PTE LTD

    Prof. Dr. Martin Schulz

  82. Lipidpneumonie durch Lipid-haltige Nasensprays und -tropfen

    Article • Laryngo-Rhino-Otologie, August 2016, Thieme Publishing Group

    Prof. Dr. Martin Schulz

  83. Evaluating patients’ comprehensibility of a standardized medication plan

    Article • European Journal of Clinical Pharmacology, June 2016, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  84. Patients’ handling of a standardized medication plan: a pilot study and method development

    Article • Patient Preference and Adherence, April 2016, Dove Medical Press

    Prof. Dr. Martin Schulz

  85. Erratum to: Medical care and drug-related problems: Do doctors and pharmacists speak the same language?

    Article • International Journal of Clinical Pharmacy, March 2016, Springer Science + Business Media

    Prof. Dr. Martin Schulz, Dr martin c henman

  86. Medical care and drug-related problems: Do doctors and pharmacists speak the same language?

    Article • International Journal of Clinical Pharmacy, January 2016, Springer Science + Business Media

    Prof. Dr. Martin Schulz, Dr martin c henman

  87. Adherence to Disease Modifying Drugs among Patients with Multiple Sclerosis in Germany: A Retrospective Cohort Study

    Article • PLOS One, July 2015, PLOS

    Prof. Dr. Martin Schulz

  88. Detection of pyrrolizidine alkaloids in German licensed herbal medicinal teas

    Article • Phytomedicine, June 2015, Elsevier

    Prof. Dr. Martin Schulz

  89. Age-related medication adherence in patients with chronic heart failure: A systematic literature review

    Article • International Journal of Cardiology, April 2015, Elsevier

    Prof. Dr. Martin Schulz

  90. Chronische Herzinsuffizienz: Teufelskreis aus geringer Einnahmetreue von Medikamenten und kardialer Dekompensation

    Article • DMW - Deutsche Medizinische Wochenschrift, November 2014, Thieme Publishing Group

    Prof. Dr. Martin Schulz

  91. Analyses of drugs stored at home by elderly patients with chronic heart failure

    Article • Clinical Research in Cardiology, November 2014, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  92. Verordnung von Hypnotika und Tranquillanzien für GKV-Versicherte auf Privatrezept: Rahmenbedingungen kontra Versorgungsrealität?

    Article • DMW - Deutsche Medizinische Wochenschrift, May 2014, Thieme Publishing Group

    Prof. Dr. Martin Schulz

  93. Dosage strength is associated with medication persistence with Ginkgo biloba drug products: a cohort study of ambulatory drug claims data in Germany

    Article • BMC Complementary and Alternative Medicine, October 2013, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  94. Drug-related problems in prescribed medicines in Germany at the time of dispensing

    Article • International Journal of Clinical Pharmacy, April 2013, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  95. Adherence to antihypertensives: feasibility of two self-report instruments to investigate medication-taking behaviour in German community pharmacies

    Article • International Journal of Pharmacy Practice, October 2012, Oxford University Press (OUP)

    Prof. Dr. Martin Schulz

  96. Betreuung von Patienten mit Herzinsuffizienz

    Article • Pharmazie in unserer Zeit, July 2012, Wiley

    Prof. Dr. Martin Schulz

  97. Editorial: Pharmazie in unserer Zeit 4/2012

    Article • Pharmazie in unserer Zeit, July 2012, Wiley

    Prof. Dr. Martin Schulz

  98. Medikationsmanagement

    Article • Pharmazie in unserer Zeit, July 2012, Wiley

    Prof. Dr. Martin Schulz

  99. Selbstmedikation: Beratung bei der Selbstbehandlung

    Article • Pharmazie in unserer Zeit, July 2012, Wiley

    Prof. Dr. Martin Schulz

  100. Incidence of thyroid hormone therapy in patients treated with sunitinib or sorafenib: A cohort study

    Article • European Journal of Cancer, May 2012, Elsevier

    Prof. Dr. Martin Schulz

  101. Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics

    Article • Critical Care, January 2012, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  102. Treatment duration (persistence) of basal insulin supported oral therapy (BOT) in Type-2 diabetic patients: comparison of insulin glargine with NPH insulin

    Article • International Journal of Clinical Pharmacology and Therapeutics, January 2012, Dustri-Verlgag Dr. Karl Feistle

    Prof. Dr. Martin Schulz

  103. Adherence to guidelines for antibiotic prophylaxis in surgery patients in German hospitals: a multicentre evaluation involving pharmacy interns

    Article • Infection, October 2011, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  104. Nature and frequency of drug-related problems in self-medication (over-the-counter drugs) in daily community pharmacy practice in Germany

    Article • Pharmacoepidemiology and Drug Safety, September 2011, Wiley

    Prof. Dr. Martin Schulz

  105. Generic switch after ramipril patent expiry is not associated with decreased pharmacy refill compliance

    Article • Journal of Hypertension, September 2011, Wolters Kluwer Health

    Prof. Dr. Martin Schulz

  106. Strategien zur Verbesserung der Einnahmetreue von Medikamenten

    Article • DMW - Deutsche Medizinische Wochenschrift, August 2011, Thieme Publishing Group

    Prof. Dr. Martin Schulz

  107. Development of a classification system for drug-related problems in the hospital setting (APS-Doc) and assessment of the inter-rater reliability

    Article • Journal of Clinical Pharmacy and Therapeutics, July 2011, Hindawi Publishing Corporation

    Prof. Dr. Martin Schulz

  108. Compliance With Antithrombotic Guidelines in Surgery Patients in German Hospitals

    Article • Clinical and Applied Thrombosis/Hemostasis, July 2011, SAGE Publications

    Prof. Dr. Martin Schulz

  109. Pharmacist-led intervention study to improve inhalation technique in asthma and COPD patients

    Article • Journal of Evaluation in Clinical Practice, August 2010, Wiley

    Prof. Dr. Martin Schulz

  110. Versorgungsmanagement für Menschen mit Asthma – Einbindung der Apotheker

    Article • Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen, January 2010, Elsevier

    Prof. Dr. Martin Schulz

  111. DB2 PERSISTENCE WITH BASAL SUPPORTED ORAL THERAPY—COMPARISON OF INSULIN GLARGINE VERSUS NPH INSULIN

    Article • Value in Health, October 2009, Elsevier

    Prof. Dr. Martin Schulz

  112. Klinisch relevante Interaktion zwischen Clopidogrel und Protonenpumpen‐Inhibitoren

    Article • Pharmazie in unserer Zeit, July 2009, Wiley

    Prof. Dr. Martin Schulz

  113. Monoclonal antibody to the prostate specific antigen: Monoklonaler Antikörper gegen das Prostata-spezifische Antigen

    Article • Andrologia, April 2009, Wiley

    Prof. Dr. Martin Schulz

  114. Mineralstoffe und Spurenelemente – ein Fall für die Beratung. In der Apotheke

    Article • Pharmazie in unserer Zeit, April 2009, Wiley

    Prof. Dr. Martin Schulz

  115. Beratung von Hustenpatienten in der Apotheke. Wann ist Selbstmedikation möglich?

    Article • Pharmazie in unserer Zeit, October 2008, Wiley

    Prof. Dr. Martin Schulz

  116. Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations

    Article • Journal of Neurology, October 2008, Springer Science + Business Media

    Professor Tjalf Ziemssen, Prof. Dr. Martin Schulz

  117. Intoxikation mit Gallopamil: Verlauf und Therapie

    Article • DMW - Deutsche Medizinische Wochenschrift, March 2008, Thieme Publishing Group

    Prof. Dr. Martin Schulz

  118. Survey of Drug-Related Problems Identified by Community Pharmacies

    Article • Annals of Pharmacotherapy, September 2007, SAGE Publications

    Prof. Dr. Martin Schulz

  119. Prävention des Diabetes mellitus - Im Fokus die Rolle der Apotheken

    Article • Diabetes aktuell, April 2007, Thieme Publishing Group

    Prof. Dr. Martin Schulz

  120. Pharmacy interns on the ward—a pilot study

    Article • Pharmacy World & Science, February 2007, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  121. German national drug information service: user satisfaction and potential positive patient outcomes

    Article • Pharmacy World & Science, January 2007, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  122. Duplicate use of angiotesin-converting enzyme (ACE) inhibitors in a community-dwelling elderly population in Poland

    Article • Archives of Gerontology and Geriatrics, January 2007, Elsevier

    Prof. Dr. Martin Schulz

  123. Community pharmacy-based intervention to improve self-monitoring of blood glucose in type 2 diabetic patien

    Article • Pharmacy Practice, December 2006, Instituto de Salud Carlos III/BNCS/SciELO Espana

    Prof. Dr. Martin Schulz

  124. Definition von Übergewicht und Adipositas: Bewertungskriterien im Wandel der Zeit

    Article • Pharmazie in unserer Zeit, November 2006, Wiley

    Prof. Dr. Martin Schulz

  125. Nahrungsergänzungsmittel bei Übergewicht und Adipositas: Produkte mit hohem Beratungsbedarf

    Article • Pharmazie in unserer Zeit, November 2006, Wiley

    Prof. Dr. Martin Schulz

  126. Safety and usage pattern of an over-the-counter ambroxol cough syrup: a community pharmacy-based cohort study

    Article • International Journal of Clinical Pharmacology and Therapeutics, September 2006, Dustri-Verlgag Dr. Karl Feistle

    Prof. Dr. Martin Schulz

  127. Klinisch‐pharmazeutische Beratung bei der Diuretikatherapie: Beitrag der Apotheke

    Article • Pharmazie in unserer Zeit, June 2006, Wiley

    Prof. Dr. Martin Schulz

  128. Pharmaceutical Care in Community Pharmacies: Practice and Research in Germany

    Article • Annals of Pharmacotherapy, April 2006, SAGE Publications

    Prof. Dr. Martin Schulz

  129. Article • Critical Care, January 2006, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  130. Community Pharmacy–Based Pharmaceutical Care for Asthma Patients

    Article • Annals of Pharmacotherapy, November 2005, SAGE Publications

    Prof. Dr. Martin Schulz

  131. Comment: when does pharmaceutical care impact health outcomes? A comparison of community pharmacy-based studies of pharmaceutical care for patients with asthma

    Article • Annals of Pharmacotherapy, July 2005, SAGE Publications

    Prof. Dr. Martin Schulz

  132. Partizipative Entscheidungsfindung als neuer Qualit�tsindikator in der Nephrologie

    Article • Medizinische Klinik, April 2005, Springer Science + Business Media

    Professor Holger Pfaff, Prof. Dr. Martin Schulz

  133. Counselling quality in community pharmacies: implementation of the pseudo customer methodology in Germany

    Article • Journal of Clinical Pharmacy and Therapeutics, February 2005, Hindawi Publishing Corporation

    Prof. Dr. Martin Schulz

  134. Pharmaceutical care, European developments in concepts, implementation, teaching, and research: a review

    Article • Pharmacy World & Science, December 2004, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  135. Wichtig für die Praxis: Moderne Antidepressiva in der Pharmazeutischen Betreuung

    Article • Pharmazie in unserer Zeit, July 2004, Wiley

    Prof. Dr. Martin Schulz

  136. Selbstmedikation - ökonomische sozialpharmakologische und toxikologische Aspekte

    Article • DMW - Deutsche Medizinische Wochenschrift, April 2004, Thieme Publishing Group

    Prof. Dr. Martin Schulz

  137. Pharmazeutische Betreuung bei Langzeitmedikation: Zwischen Cortisonangst und ‐euphorie

    Article • Pharmazie in unserer Zeit, July 2003, Wiley

    Prof. Dr. Martin Schulz

  138. Pharmacist Care for Reactive Airway Disease

    Article • JAMA, March 2003, American Medical Association (AMA)

    Prof. Dr. Martin Schulz

  139. Pharmazeutische Betreuung von Demenzpatienten und deren Angehörigen: Im Mittelpunkt: Der Mensch

    Article • Pharmazie in unserer Zeit, July 2002, Wiley

    Prof. Dr. Martin Schulz

  140. Immunmodulatorische Stufentherapie der Multiplen SkleroseNeue Aspekte und praktische Umsetzung, März 2002

    Article • Der Nervenarzt, June 2002, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  141. Dark Remedy: The Impact of Thalidomide and its Revival as a Vital Medicine

    Article • BMJ, June 2001, BMJ

    Prof. Dr. Martin Schulz

  142. Pharmaceutical Care Services for Asthma Patients: A Controlled Intervention Study

    Article • The Journal of Clinical Pharmacology, June 2001, Wiley

    Prof. Dr. Martin Schulz

  143. Immunmodulatorische Stufentherapie der multiplen Sklerose

    Article • Der Nervenarzt, February 2001, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  144. Lack of Methemoglobinemia with Flutamide

    Article • Annals of Pharmacotherapy, January 2001, SAGE Publications

    Prof. Dr. Martin Schulz

  145. Fatal intoxication with melperone

    Article • Forensic Science International, September 2000, Elsevier

    Prof. Dr. Martin Schulz

  146. Meinungen und Einstellungen zum Thema Impfen bei niedergelassenen Ärzten, Offizinapothekern und ihrem Personal sowie aktueller Impfstatus dieser Gruppen

    Article • Das Gesundheitswesen, July 2000, Thieme Publishing Group

    Prof. Dr. Martin Schulz

  147. Selbstmedikation - ökonomische sozialpharmakologische und toxikologische Aspekte

    Article • DMW - Deutsche Medizinische Wochenschrift, January 2000, Thieme Publishing Group

    Prof. Dr. Martin Schulz

  148. Vergiftungs- und Todesfälle durch Substitutionsmittel im Umfeld von substituierten Drogenabhängigen

    Article • Rechtsmedizin, April 1999, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  149. Clinical Pharmacokinetics of Alfentanil, Fentanyl and Sufentanil

    Article • Clinical Pharmacokinetics, October 1996, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  150. Fluconazole is removed by continuous venovenous hemofiltration in a liver transplant patient

    Article • Journal of Molecular Medicine, March 1995, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  151. Zusammenstellung therapeutischer und toxischer Plasmakonzentrationsbereiche von Arzneistoffen

    Article • Der Anaesthesist, December 1994, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  152. Pharmacokinetics and effects on intracranial pressure of sufentanil in head trauma patients.

    Article • British Journal of Clinical Pharmacology, October 1994, Wiley

    Prof. Dr. Martin Schulz

  153. Comment: Drug Information Centers in Europe

    Article • Annals of Pharmacotherapy, September 1992, SAGE Publications

    Prof. Dr. Martin Schulz

  154. Therapeutische und toxische Plasmakonzentrationen sowie Eliminationshalbwertszeiten gebräuchlicher Arzneistoffe

    Article • AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie, February 1991, Thieme Publishing Group

    Prof. Dr. Martin Schulz

  155. Monoclonal antibody that defines the prostate specific antigen

    Article • The Prostate, January 1989, Wiley

    Prof. Dr. Martin Schulz

  156. On the sulphoxidation of cimetidine and etintidine by rat and human liver microsomes

    Article • Xenobiotica, January 1988, Taylor & Francis

    Prof. Dr. Martin Schulz

  157. The pharmacokinetics of flutamide and its major metabolites after a single oral dose and during chronic treatment

    Article • European Journal of Clinical Pharmacology, January 1988, Springer Science + Business Media

    Prof. Dr. Martin Schulz

  158. Interactions of the histamine H2-receptor antagonist etintidine with rat liver cytochrome P-450: a comparison with cimetidine

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, October 1987, Springer Science + Business Media

    Prof. Dr. Martin Schulz